A citation-based method for searching scientific literature

Lena In der Stroth, Umesh Tharehalli, Cagatay Günes, André Lechel. Cancers (Basel) 2020
Times Cited: 7







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
364
42

TERT promoter mutations in primary liver tumors.
Jean-Charles Nault, Jessica Zucman-Rossi. Clin Res Hepatol Gastroenterol 2016
51
42

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M Llovet. Gastroenterology 2015
539
42

The role of telomeres and telomerase in cirrhosis and liver cancer.
Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, Jessica Zucman-Rossi. Nat Rev Gastroenterol Hepatol 2019
53
42

Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Haeryoung Kim, Jeong Eun Yoo, Jai Young Cho, Bong-Kyeong Oh, Yoo-Seok Yoon, Ho-Seong Han, Hye Seung Lee, Ja June Jang, Sook Hyang Jeong, Jin Wook Kim,[...]. J Hepatol 2013
41
28

Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
Jean Charles Nault, Julien Calderaro, Luca Di Tommaso, Charles Balabaud, Elie Serge Zafrani, Paulette Bioulac-Sage, Massimo Roncalli, Jessica Zucman-Rossi. Hepatology 2014
171
28

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Yasushi Totoki, Kenji Tatsuno, Kyle R Covington, Hiroki Ueda, Chad J Creighton, Mamoru Kato, Shingo Tsuji, Lawrence A Donehower, Betty L Slagle, Hiromi Nakamura,[...]. Nat Genet 2014
407
28

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Kornelius Schulze, Sandrine Imbeaud, Eric Letouzé, Ludmil B Alexandrov, Julien Calderaro, Sandra Rebouissou, Gabrielle Couchy, Clément Meiller, Jayendra Shinde, Frederic Soysouvanh,[...]. Nat Genet 2015
761
28

TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.
Roser Pinyol, Victoria Tovar, Josep M Llovet. J Hepatol 2014
30
28

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto,[...]. J Gastroenterol 2016
53
28

Revisiting Telomere Shortening in Cancer.
Keiji Okamoto, Hiroyuki Seimiya. Cells 2019
40
28


Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Massih Ningarhari, Stefano Caruso, Théo Z Hirsch, Quentin Bayard, Andrea Franconi, Anne-Laure Védie, Bénédicte Noblet, Jean-Frédéric Blanc, Giuliana Amaddeo, Nathalie Ganne,[...]. J Hepatol 2021
7
28

Liver transplantation for hilar cholangiocarcinoma: A systematic review.
Nikolaos Machairas, Ioannis D Kostakis, Diamantis I Tsilimigras, Anastasia Prodromidou, Dimitrios Moris. Transplant Rev (Orlando) 2020
3
33

Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant.
Alessandro Cucchetti, Matteo Serenari, Carlo Sposito, Stefano Di Sandro, Cristina Mosconi, Ilaria Vicentin, Enrico Garanzini, Vincenzo Mazzaferro, Luciano De Carlis, Rita Golfieri,[...]. J Hepatol 2020
12
14

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, Heike Bantel, Stefano Bellentani, Joan Caballeria, Massimo Colombo, Antonio Craxi, Javier Crespo, Christopher P Day,[...]. J Hepatol 2018
344
14

Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
Jessica L Petrick, Scott P Kelly, Sean F Altekruse, Katherine A McGlynn, Philip S Rosenberg. J Clin Oncol 2016
184
14

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.
V Mazzaferro, E Regalia, R Doci, S Andreola, A Pulvirenti, F Bozzetti, F Montalto, M Ammatuna, A Morabito, L Gennari. N Engl J Med 1996
14

Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial.
Vincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, Marco Bongini, Rosalba Miceli, Luciano De Carlis, Michele Colledan, Mauro Salizzoni, Renato Romagnoli, Barbara Antonelli,[...]. Lancet Oncol 2020
24
14

The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
Kazunari Sasaki, Daisuke Morioka, Simone Conci, Georgios A Margonis, Yu Sawada, Andrea Ruzzenente, Takafumi Kumamoto, Calogero Iacono, Nikolaos Andreatos, Alfredo Guglielmi,[...]. Ann Surg 2018
75
14

Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.
Xavier Muller, Francesca Marcon, Gonzalo Sapisochin, Max Marquez, Federica Dondero, Michel Rayar, Majella M B Doyle, Lauren Callans, Jun Li, Greg Nowak,[...]. Ann Surg 2018
66
14

Immunotherapy as a Downstaging Therapy for Liver Transplantation.
Birgit Schwacha-Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour. Hepatology 2020
9
14

Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA.
Eliza W Beal, Dmitry Tumin, Ali Kabir, Dimitrios Moris, Xu-Feng Zhang, Jeffery Chakedis, Kenneth Washburn, Sylvester Black, Carl M Schmidt, Timothy M Pawlik. World J Surg 2018
13
14

Textbook Outcomes in Liver Transplantation.
Dimitrios Moris, Brian I Shaw, Jared Gloria, Samuel J Kesseli, Mariya L Samoylova, Robin Schmitz, Miriam Manook, Lisa M McElroy, Yuval Patel, Carl L Berg,[...]. World J Surg 2020
11
14

Survival advantage for patients accepting the offer of a circulatory death liver transplant.
Rhiannon Taylor, Elisa Allen, James A Richards, Mingzheng A Goh, James Neuberger, David Collett, Gavin J Pettigrew. J Hepatol 2019
24
14

Mechanisms of liver-induced tolerance.
Demetrios Moris, Lina Lu, Shiguang Qian. Curr Opin Organ Transplant 2017
22
14

Inflammatory Mechanisms of HCC Development.
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr, Rosalba D'Alessandro. Cancers (Basel) 2020
21
14



Liver transplantation for unresectable colorectal liver metastases: A systematic review.
Dimitrios Moris, Diamantis I Tsilimigras, Jeffery Chakedis, Eliza W Beal, Evangelos Felekouras, Spiridon Vernadakis, Dimitrios Schizas, John J Fung, Timothy M Pawlik. J Surg Oncol 2017
35
14

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update.
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Michail Vailas, Dimitrios Moris, Efthymios Gkotsis, Stylianos Kykalos, Michalis V Karamouzis, Dimitrios Schizas. Cancers (Basel) 2020
17
14


Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.
Dimitrios Moris, Ioannis D Kostakis, Nikolaos Machairas, Anastasia Prodromidou, Diamantis I Tsilimigras, Kadiyala V Ravindra, Debra L Sudan, Stuart J Knechtle, Andrew S Barbas. PLoS One 2019
20
14

The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma.
Demetrios Moris, Spyridon Vernadakis, Alexandros Papalampros, Athanasios Petrou, Dimitrios Dimitroulis, Eleftherios Spartalis, Evangelos Felekouras, John J Fung. J BUON 2016
9
14

Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.
Sepideh Gholami, Lauren M Perry, Jason W Denbo, Kenneth Chavin, Philippa Newell, Quan Ly, Charles St Hill, Gareth Morris-Stiff, Jonathan Kessler, Timothy L Frankel,[...]. HPB (Oxford) 2021
1
100

Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.
Svein Dueland, Trygve Syversveen, Jon Magnus Solheim, Steinar Solberg, Harald Grut, Bjørn Atle Bjørnbeth, Morten Hagness, Pål-Dag Line. Ann Surg 2020
51
14

Role of exosomes in treatment of hepatocellular carcinoma.
Demetrios Moris, Eliza W Beal, Jeffery Chakedis, Richard A Burkhart, Carl Schmidt, Mary Dillhoff, Xufeng Zhang, Stamatios Theocharis, Timothy M Pawlik. Surg Oncol 2017
21
14

Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
D I Tsilimigras, D Moris, J M Hyer, F Bagante, K Sahara, A Moro, A Z Paredes, R Mehta, F Ratti, H P Marques,[...]. Br J Surg 2020
17
14

Hepatocellular carcinoma.
Alejandro Forner, Josep M Llovet, Jordi Bruix. Lancet 2012
14

Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Ani Kardashian, Sander S Florman, Brandy Haydel, Richard M Ruiz, Goran B Klintmalm, David D Lee, C Burcin Taner, Federico Aucejo, Amit D Tevar, Abhinav Humar,[...]. Hepatology 2020
16
14

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
Diamantis I Tsilimigras, Rittal Mehta, Dimitrios Moris, Kota Sahara, Fabio Bagante, Anghela Z Paredes, Ayesha Farooq, Francesca Ratti, Hugo P Marques, Silvia Silva,[...]. Ann Surg Oncol 2020
15
14

Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.
Gang Wang, Qian Wang, Ning Liang, Hongyuan Xue, Tao Yang, Xuguang Chen, Zhaoyan Qiu, Chao Zeng, Tao Sun, Weitang Yuan,[...]. Cell Death Dis 2020
15
14

Liver resection and transplantation for intrahepatic cholangiocarcinoma.
Vincenzo Mazzaferro, Andre Gorgen, Sasan Roayaie, Michele Droz Dit Busset, Gonzalo Sapisochin. J Hepatol 2020
30
14

Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
Dimitrios Moris, Diamantis I Tsilimigras, Ioannis Ntanasis-Stathopoulos, Eliza W Beal, Evangelos Felekouras, Spiridon Vernadakis, John J Fung, Timothy M Pawlik. Surgery 2017
41
14

Liver Transplantation Following Yttrium-90 Radioembolization: 15-Year Experience in 207-Patient Cohort.
Ahmed Gabr, Laura Kulik, Samdeep Mouli, Ahsun Riaz, Rehan Ali, Kush Desai, Ronald A Mora, Daniel Ganger, Haripriya Maddur, Steven Flamm,[...]. Hepatology 2021
10
14

Challenges to liver transplantation and strategies to improve outcomes.
Philipp Dutkowski, Michael Linecker, Michelle L DeOliveira, Beat Müllhaupt, Pierre-Alain Clavien. Gastroenterology 2015
143
14

Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
Diamantis I Tsilimigras, Fabio Bagante, Dimitrios Moris, Katiuscha Merath, Anghela Z Paredes, Kota Sahara, Francesca Ratti, Hugo P Marques, Olivier Soubrane, Vincent Lam,[...]. Surgery 2019
16
14

Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4,089 Patients.
Daniel J Firl, Kazunari Sasaki, Vatche G Agopian, Andre Gorgen, Shoko Kimura, Wethit Dumronggittigule, John C McVey, Samuele Iesari, Gianluca Mennini, Alessandro Vitale,[...]. Hepatology 2020
13
14

Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
Neil Mehta, Julie Heimbach, Denise M Harnois, Gonzalo Sapisochin, Jennifer L Dodge, David Lee, Justin M Burns, William Sanchez, Paul D Greig, David R Grant,[...]. JAMA Oncol 2017
111
14

Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy.
Daniel J Firl, Shoko Kimura, John McVey, Koji Hashimoto, Heidi Yeh, Charles M Miller, James F Markmann, Kazunari Sasaki, Federico N Aucejo. Hepatology 2018
13
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.